Commercial Model Innovation Critical To Win China: McKinsey
This article was originally published in PharmAsia News
Executive Summary
Despite a well-tailored product lineup targeting the value market segment being high on top medical device executives’ minds, a more sophisticated commercial model will help win the day in China. In effect, a key shift away from fast sales force expansion towards sophistication and specialization is emerging in the country, notes a new McKinsey study.